| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 276 |
| 1 | ETANERCEPT | 201 |
| 2 | UPADACITINIB | 179 |
| 3 | RISANKIZUMAB-RZAA | 139 |
| 4 | GABAPENTIN | 130 |
| 5 | DUPILUMAB | 96 |
| 6 | TOFACITINIB | 93 |
| 7 | METHOTREXATE SODIUM | 91 |
| 8 | METHOTREXATE | 89 |
| 9 | OXYCODONE HYDROCHLORIDE | 87 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | 13 | 0.0036 |
| 1 | ERGOCALCIFEROL | 84 | 0.0028 |
| 2 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 30 | 0.0025 |
| 3 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 20 | 0.0022 |
| 4 | UPADACITINIB | 179 | 0.0021 |
| 5 | ELOSULFASE ALFA | 11 | 0.0020 |
| 6 | CLINDAMYCIN PHOSPHATE | 11 | 0.0020 |
| 7 | UBROGEPANT | 12 | 0.0019 |
| 8 | GOLIMUMAB | 19 | 0.0015 |
| 9 | METHOCARBAMOL TABLETS | 25 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 254 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 189 |
| 2 | Janus Kinase Inhibitor [EPC] | 180 |
| 3 | Interleukin-23 Antagonist [EPC] | 164 |
| 4 | Corticosteroid [EPC] | 134 |
| 5 | Benzodiazepine [EPC] | 120 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 96 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 87 |
| 8 | Provitamin D2 Compound [EPC] | 84 |
| 9 | Proton Pump Inhibitor [EPC] | 80 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 13 | 0.0189 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 12 | 0.0058 |
| 2 | Adrenocorticotropic Hormone [EPC] | 4 | 0.0045 |
| 3 | Provitamin D2 Compound [EPC] | 84 | 0.0028 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 19 | 0.0027 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 21 | 0.0016 |
| 6 | Interleukin-23 Antagonist [EPC] | 164 | 0.0016 |
| 7 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 8 | PCSK9 Inhibitor [EPC] | 33 | 0.0013 |
| 9 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |